Back to search
FDAFDA · Food and drugs·Recall number D-1494-2016

ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-0020-31 (Single Use Bag), NDC # 0703-0020-32 (5 Single Use Bags in One Carton).

Published September 14, 2016 · Recall initiated: June 17, 2016

Summary

FDA records drug Class II recall D-1494-2016, published September 14, 2016 and initiated June 17, 2016. Recalling firm: Teva North America; Status: Terminated; Reported quantity: 1,299 bags; Lot: All lots within Expiry. Lot # 4720915, 6790315, 6800315, 6810315, 6820315. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva North America
Distributor
Nationwide and Puerto Rico
Lot
All lots within Expiry. Lot # 4720915, 6790315, 6800315, 6810315, 6820315
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-0020-31 (Single Use Bag), NDC # 0703-0020-32 (5 Single Use Bags in One Carton). recalled?

Yes. FDA published recall D-1494-2016 on September 14, 2016. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter